| Product Code: ETC13364601 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Peripheral Intervention Drug-Eluting Devices Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Peripheral Intervention Drug-Eluting Devices Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume, 2021 & 2031F |
3.3 North America Peripheral Intervention Drug-Eluting Devices Market - Industry Life Cycle |
3.4 North America Peripheral Intervention Drug-Eluting Devices Market - Porter's Five Forces |
3.5 North America Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.7 North America Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Coating Material, 2021 & 2031F |
3.8 North America Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 North America Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 North America Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 North America Peripheral Intervention Drug-Eluting Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Peripheral Intervention Drug-Eluting Devices Market Trends |
6 North America Peripheral Intervention Drug-Eluting Devices Market, 2021 - 2031 |
6.1 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Drug-Eluting Stents, 2021 - 2031 |
6.1.3 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Drug-Eluting Balloons, 2021 - 2031 |
6.1.4 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Biodegradable Stents, 2021 - 2031 |
6.1.5 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Polymer-Based Stents, 2020 - 2028 |
6.1.6 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Hybrid Coated Stents, 2020 - 2028 |
6.2 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Coating Material, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Sirolimus, 2021 - 2031 |
6.2.3 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Paclitaxel, 2021 - 2031 |
6.2.4 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Everolimus, 2021 - 2031 |
6.2.5 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Zotarolimus, 2021 - 2031 |
6.2.6 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Rapamycin, 2020 - 2028 |
6.3 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Peripheral Artery Disease, 2021 - 2031 |
6.3.3 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Chronic Limb Ischemia, 2021 - 2031 |
6.3.4 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Deep Vein Thrombosis, 2021 - 2031 |
6.3.5 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Aneurysm Repair, 2021 - 2031 |
6.3.6 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Stenosis Treatment, 2021 - 2031 |
6.4 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.2 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.4.4 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Ambulatory Centers, 2020 - 2028 |
6.4.5 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Research Institutes, 2020 - 2028 |
6.4.6 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Cardiac Care Centers, 2020 - 2028 |
6.5 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Technology, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Nanocoating, 2020 - 2028 |
6.5.3 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Biodegradable Coating, 2020 - 2028 |
6.5.4 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Sustained Drug Release, 2020 - 2028 |
6.5.5 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Polymer-Encapsulated, 2020 - 2028 |
6.5.6 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Targeted Drug Delivery, 2020 - 2028 |
7 North America Peripheral Intervention Drug-Eluting Devices Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.2.1 United States (US) Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.2.2 Canada Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.2.3 Rest of North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Device Type, 2021 - 2031 |
7.3 North America Peripheral Intervention Drug-Eluting Devices Market Revenues & Volume Share, By Coating Material, 2021 & 2031F |
7.3.1 United States (US) Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Coating Material, 2021 - 2031 |
7.3.2 Canada Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Coating Material, 2021 - 2031 |
7.3.3 Rest of North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Coating Material, 2021 - 2031 |
7.4 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.1 United States (US) Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.2 Canada Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4.3 Rest of North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United States (US) Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Canada Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 Rest of North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.1 United States (US) Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.2 Canada Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.3 Rest of North America Peripheral Intervention Drug-Eluting Devices Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 North America Peripheral Intervention Drug-Eluting Devices Market Key Performance Indicators |
9 North America Peripheral Intervention Drug-Eluting Devices Market - Export/Import By Countries Assessment |
10 North America Peripheral Intervention Drug-Eluting Devices Market - Opportunity Assessment |
10.1 North America Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Device Type, 2021 & 2031F |
10.3 North America Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Coating Material, 2021 & 2031F |
10.4 North America Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
10.5 North America Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By End User, 2021 & 2031F |
10.6 North America Peripheral Intervention Drug-Eluting Devices Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 North America Peripheral Intervention Drug-Eluting Devices Market - Competitive Landscape |
11.1 North America Peripheral Intervention Drug-Eluting Devices Market Revenue Share, By Companies, 2022 |
11.2 North America Peripheral Intervention Drug-Eluting Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here